Department of Urology, Frederiksberg/Herlev Hospital, Herlev, Denmark.
Department of Urology, Vestre Viken Baerum Hospital, Drammen, Norway.
World J Urol. 2019 Aug;37(8):1615-1621. doi: 10.1007/s00345-018-2537-7. Epub 2018 Oct 26.
To evaluate on a lesion-by-lesion basis Narrow-Band Imaging flexible videoscopy (NBI-FV) in the detection of cancer compared to White-Light Imaging flexible videoscopy (WLI-FV).
WLI-FV and NBI-FV were sequentially performed in patients scheduled for TURBT for primary bladder cancer. Suspicious findings were individually harvested and characterized under WLI-FV (suspicious/non-suspicious) and NBI-FV (5-point Likert scale) and pathology. The primary objective was to determine if NBI-FV informed at least 20% more cancer lesions than WLI-FV (Relative true-positive rate > 1.19). A minimum of 120 specimens was to be analyzed to reach 90% power.
Of 147 specimens taken in 68 patients, 101 were found suspicious under WLI-FV and 64 (64/101, 63.4%) confirmed as cancer. Of the 46 lesions undetected by WLI-VF, 16 were found positive for cancer (16/46, 34.8%). For NBI-FV, a significant increase in positive samples was observed with increments in Likert scale (p < 0.0002). Relative true-positive rate was 1.22 (95% CI 1.12-1.39)-NBI-FV detected 22% more cancer lesions compared to WLI-FV. Relative false-positive rate was 1.35 (95% CI 1.19-1.59).
Researching alterations in mucosa and microvasculature by narrow-band imaging flexible videoscopy augmented by 22% the detection of cancer foci and contributed to the objective of complete resection of all visible lesions. Conversely, it entailed a 35% increase in false-positive results compared to white-light imaging, although the structured analysis of narrow-band imaging findings might be used to grade suspicion according to the Likert scale and balance the risk of a false-positive result to the benefit of demonstrating cancer.
评估窄带成像(NBI)膀胱镜与白光成像(WLI)膀胱镜对膀胱癌病变的检测能力。
对因原发性膀胱癌而拟行经尿道膀胱肿瘤切除术(TURBT)的患者,依次行 WLI 膀胱镜和 NBI 膀胱镜检查。单独采集可疑发现,并分别在 WLI 膀胱镜下(可疑/非可疑)和 NBI 膀胱镜下(5 分 Likert 量表)以及病理上进行特征描述。主要目的是确定 NBI 膀胱镜是否能比 WLI 膀胱镜多发现至少 20%的癌症病变(相对真阳性率 > 1.19)。至少要分析 120 个标本,才能达到 90%的功率。
68 例患者的 147 个标本中,101 个在 WLI 膀胱镜下被怀疑为膀胱癌,64 个(64/101,63.4%)被确认为癌症。在 WLI-VF 未检测到的 46 个病变中,有 16 个为癌症阳性(16/46,34.8%)。对于 NBI 膀胱镜,Likert 量表评分的增加与阳性样本的显著增加相关(p < 0.0002)。相对真阳性率为 1.22(95%CI 1.12-1.39),与 WLI-FV 相比,NBI-FV 检测到 22%更多的癌症病变。相对假阳性率为 1.35(95%CI 1.19-1.59)。
通过窄带成像柔性膀胱镜研究黏膜和微血管结构的改变,使癌症病灶的检出率提高了 22%,有助于实现完全切除所有可见病灶的目标。相反,与白光成像相比,这导致假阳性结果增加了 35%,尽管窄带成像结果的结构化分析可以根据 Likert 量表对可疑程度进行分级,并平衡假阳性结果的风险,以展示癌症的获益。